By Jason Barker
Published: Wed, June 20, 2018 12:00 AM
GO PRO Support local journalism by upgrading to NewsOK Pro.
Regarding “Research weakens medical pot claims” (Our Views, June 17): There are more studies published (over 25,000) about the safe medical uses of cannabis than there are research studies for Tylenol.
I’m curious why The Oklahoman editorial board did not discuss U.S. Patent 6630507? The U.S. Patent Office issued Patent 6630507 to the U.S. Department of Health and Human Services filed on Feb. 2, 2001. The patent covers the potential use of cannabinoids — chemical compounds found within the plant species cannabis sativa — to protect the brain from damage or degeneration caused by certain diseases, treating neurological diseases, such as Alzheimer’s, Parkinson’s and stroke, and diseases caused by oxidative stress, such as heart attack, Crohn’s disease, diabetes and arthritis. Patent No. 6630507 was granted to the U.S. Department of Health and Human Services in 2003.
Another concern in the editorial is this statement: “Neither has marijuana been proven to help people abstain from other addictive substances.” In the next decade, opioid abuse may kill nearly half a million people — but an obvious solution remains conspicuous by its absence. Americans make up only about 5 percent of the world’s population, but use more than 80 percent of the world’s supply of opioids — a class of powerful pain-killing drugs that accounts for nearly 115 overdose deaths per day, outstripping all other accidental causes of death and robbing many of our nation’s military veterans of their life.
And there are already a few clinics in the U.S. treating addiction very successfully with medical cannabis, like High Sobriety in Los Angeles.
From Time magazine, 1931: